Please try another search
Breaking News
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1097 | 993 | 1097 | 1187 | 1279 | 1884 |
Fund Return | 9.67% | -0.7% | 9.67% | 5.88% | 5.04% | 6.54% |
Place in category | 151 | 317 | 151 | 198 | 111 | 47 |
% in Category | 23 | 50 | 23 | 38 | 26 | 13 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JPM US Equity Income Fund X Net Acc | 3.16B | 13.72 | 8.83 | 12.71 | ||
JPM US Equity Income Fund B Net Acc | 3.16B | 13.46 | 6.29 | 10.67 | ||
JPM US Equity Income Fund B Net Inc | 3.16B | 13.48 | 6.28 | 10.67 | ||
JPM US Equity Income Fund C Net Acc | 3.16B | 13.86 | 6.66 | 11.03 | ||
JPM US Equity Income Fund C Net Inc | 3.16B | 13.86 | 6.66 | 11.03 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Index Unit Trust Accumulation | 15.05B | 9.33 | 5.76 | 6.10 | ||
All Share Index Unit Trust Income | 15.05B | 9.33 | 5.75 | 6.09 | ||
VG UK Plus GBP Accumulation | 15.05B | 9.34 | 5.76 | 6.12 | ||
VG UK Institutional Plus GBP Income | 15.05B | 9.34 | 5.75 | 6.11 | ||
UK Equity Tracker Fund X Acc | 11.63B | 9.31 | 6.12 | 6.33 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shell | GB00BP6MXD84 | 6.62 | 31.49 | -1.15% | |
AstraZeneca | GB0009895292 | 6.45 | 11,271.3 | -0.04% | |
HSBC | GB0005405286 | 6.12 | 826.64 | +0.61% | |
Unilever | GB00B10RZP78 | 4.56 | 55.54 | -0.61% | |
Relx | GB00B2B0DG97 | 2.86 | 4,002.50 | -0.36% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Neutral | Buy |
Technical Indicators | Sell | BUY | Strong Buy |
Summary | Strong Sell | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review